Skip to main content

Table 2 Patient characteristics

From: A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer

Variables

Values

SD

Age (years)

72

6.84

iPSA (ng/mL)

14.64

15.66

Gleason score

 3 + 3

9

 

 3 + 4

21

 

 4 + 3

8

 

 4 + 4

10

 

 4 + 5

4

 

 5 + 4

3

 

T stage

 1a

1

 

 1c

19

 

 2a

12

 

 2b

4

 

 2c

10

 

 3a

3

 

 3b

5

 

Risk group

 Low risk

4

 

 Intermediate risk

31

 

 High risk

20

 

Positive cores (%)

34.8

25.8

Hormonal therapy

  

 Yes

37

 

 No

18

 
  1. Values represent mean or number
  2. iPSA, initial prostate-specific antigen; SD, standard deviation
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us